TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05830630

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine methylene blue
Description: Patients in this group will receive the following regimen through the perineural catheter:~Bolus dose of 1 ml methylene blue 1% (10 mg) plus 19 ml bupivacaine 0.25% will be given intraoperatively before wound closure, and perineural infusion of methylene blue plus bupivacaine 0.25% (1 ml of methylene blue added to each 49 ml of bupivacaine 0.25%) will be started in the recovery room at a rate of 2-5 ml/hour for 72 hours postoperatively

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bupivacaine saline
Description: Patients in this group will receive the following regimen through the perineural catheter:~Bolus dose of 1 ml normal saline plus 19 ml bupivacaine 0.25% will be given intraoperatively before wound closure, and perineural infusion of bupivacaine 0.25% will be started in the recovery room at a rate of 2-5 ml/hour for 72 hours postoperatively
Study: NCT06292715

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: microwave ablation of the spleen
Description: Ultrasound-guided percutaneous puncture for splenic ablation treatment

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Splenic artery balloon implantation
Description: Splenic artery balloon implantation
Study: NCT05572619

Intervention type: DEVICE
Intervention: 1st Reading
Description: The medical team visually checks the non-contrast CT without cELVO and diagnose the large vessel occlusion.

Intervention type: DEVICE
Intervention: 1st Reading
Description: The medical team visually checks the non-contrast CT without cELVO and diagnose the large vessel occlusion.

Intervention type: DEVICE
Intervention: 2nd Reading
Description: The medical team visually checks the non-contrast CT with assistance from the cELVO and diagnose the large vessel occlusion.

Intervention type: DEVICE
Intervention: 2nd Reading
Description: The medical team visually checks the non-contrast CT with assistance from the cELVO and diagnose the large vessel occlusion.
Study: NCT05798624

Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound between 6+0 and 6+7 weeks of pregnancy
Description: Location of implantation of the GS (gestational sac) amended to Naji et al, defined as 3 possible implantation sites (A: fundal, B: anterior, C: posterior)~Size of gestational sac
Study: NCT06473272

Intervention type: OTHER
Intervention: Cardiovascular and cerebrovascular diseases
Description: Cardiovascular and cerebrovascular diseases
Study: NCT05250492

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Prosthetic hip surgery
Description: Total hip prosthesis performed by an anterior approach with intra-articular infiltration of an anesthetic product intraoperatively.~OR~- Total hip prosthesis performed by an anterior approach with infiltration of the same anesthetic product by ultrasound-guided PENG block intraoperatively.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Prosthetic hip surgery
Description: Total hip prosthesis performed by an anterior approach with intra-articular infiltration of an anesthetic product intraoperatively.~OR~- Total hip prosthesis performed by an anterior approach with infiltration of the same anesthetic product by ultrasound-guided PENG block intraoperatively.
Study: NCT06051721

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CYB004
Description: CYB004 is a synthetic deuterated N, N-Dimethyltryptamine (DMT) analog.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CYB004
Description: CYB004 is a synthetic deuterated N, N-Dimethyltryptamine (DMT) analog.
Study: NCT04817319

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Oral care with/without aerosolization
Description: These treatments involve instruments that produce aerosolization: ultrasonic scaler, rotary instrumentation for caries care, dental extraction, tooth polishing.~These care correspond to examinations of the oral cavity, intraoral X-rays or even periodontal pocket probing.
Study: NCT00280839

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topiramate

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT06263933

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Semi-directional interviews
Description: In the end of the intervention. In the end of DIPEM Or in the end of control group.~This intervention will be held after one month of hospitalization.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Semi-directional interviews
Description: In the end of the intervention. In the end of DIPEM Or in the end of control group.~This intervention will be held after one month of hospitalization.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: routine care
Description: routine care

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: session of mutual assistance with a mediator psychologist
Description: session of mutual assistance with a mediator psychologist
Study: NCT06051721

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Description: Manualized psychotherapy (called EMBARK) performed by facilitators

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychotherapy
Description: Manualized psychotherapy (called EMBARK) performed by facilitators
Study: NCT05352750

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SON-1010
Description: SON-1010 multiple ascending dose

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SON-1010
Description: SON-1010 multiple ascending dose

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SON-1010
Description: SON-1010 multiple ascending dose

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SON-1010
Description: SON-1010 multiple ascending dose

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SON-1010
Description: SON-1010 multiple ascending dose

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SON-1010
Description: SON-1010 multiple ascending dose
Study: NCT05405504

Intervention type: DEVICE
Intervention: Remote Dielectric Sensing (ReDS)
Description: Non-invasive device designed for the measurement of lung fluid using extremely low power electromagnetic waves. The ReDS Pro System V2.7 system has CE approval (3900874CE01) and FDA clearance.

Intervention type: DEVICE
Intervention: Remote Dielectric Sensing (ReDS)
Description: Non-invasive device designed for the measurement of lung fluid using extremely low power electromagnetic waves. The ReDS Pro System V2.7 system has CE approval (3900874CE01) and FDA clearance.
Study: NCT04952961

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Training in Vulval Self-Examination
Description: Face-to-face training in vulval self-examination Supplemented with use of aids ( hand mirror, mobile phone with selfie-stick), patient information leaflet, reminders to self-examine
Study: NCT06150248

Intervention type: OTHER
Group type: OTHER
Intervention: Education Intervention
Description: This intervention is based on the Social Cognitive Theory (SCT) and The Health Belief Model (HBM) to improve knowledge and promote lifestyle adherence in terms of healthy diet behaviour and physical activity among the undergraduate students. This program will include educational booklets and educational classes include six weeks of in-person education sessions and six weeks of social media messaging. The course will include six weekly teaching units (lectures and group discussions, 45-60 minutes each):~Topic 1: To understand the causes and prevention strategies for overweight and obesity.~Topic 2: To understand food based approaches to reduce or prevent overweight and obesity.~Topic 3: To understand the importance of regular physical activity. Topic 4: To demonstrate how snacking can be a healthy habit. Topic 5: To learn how to read and interpret food labels. Topic 6: To understand how to prepare healthy meals.

Intervention type: OTHER
Group type: OTHER
Intervention: No intervention
Description: They will have their regular curriculums and normal physical activity routine.
Study: NCT04564092

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DaTSCAN™ Ioflupane (123I) Injection
Description: Each participant will receive a single administration of DaTSCAN™ ioflupane (123I) injection by bolus IV injection with a nominal iodine (123I) activity of 111 MBq ±10%, in a maximum volume of 5 mL.
Study: NCT05821816

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS
Description: Use of Transcranial direct current stimulation for 20 minutes per day, 5 days a week, at 2mA

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional rehabilitative treatment
Description: Physiotherapy treatment consisting in two treatments per day of 40 minutes each

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional rehabilitative treatment
Description: Physiotherapy treatment consisting in two treatments per day of 40 minutes each
Study: NCT04981418

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: customised pelvic support shorts
Description: These apply targeted compressive forces to the pelvic girdle through selective precisely positioned reinforced lycra panels that aim to stabilize and align body segments to improve function and reduce unwanted movements. The construction material (Nylon and Elastane) is durable and breathable, and its mechanical properties enable it to provide dynamic stability and support (rather than the rigid support provided by off-the-shelf belts) during movement/functional activities. This aims to optimise comfort and movement to increase wear compliance, which is crucial as any benefits gained rely upon this.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Women will be provided with up to a maximum of 4 exercises from a pre-defined list of exercises. Suggested dosages are referred to in the protocol. The exercise programme contains a range of exercise focused around the pelvic girdle and hips (including movement control and strengthening

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Women will be provided with up to a maximum of 4 exercises from a pre-defined list of exercises. Suggested dosages are referred to in the protocol. The exercise programme contains a range of exercise focused around the pelvic girdle and hips (including movement control and strengthening

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: advice
Description: standardised advice on management of pelvic girdle pain, through a discussion centred around 'Guidance for Mothers-to-be and New Mothers: Pregnancy-related Pelvic Girdle Pain' booklet (https://pogp.csp.org.uk/system/files/pogp-pgppat_3.pdf). This publicly available, specialist physiotherapy approved, standardised leaflet, provides information reflective of current best practice. The participant can use this as an ongoing resource.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: advice
Description: standardised advice on management of pelvic girdle pain, through a discussion centred around 'Guidance for Mothers-to-be and New Mothers: Pregnancy-related Pelvic Girdle Pain' booklet (https://pogp.csp.org.uk/system/files/pogp-pgppat_3.pdf). This publicly available, specialist physiotherapy approved, standardised leaflet, provides information reflective of current best practice. The participant can use this as an ongoing resource.
Study: NCT04858932

Intervention type: DEVICE
Intervention: Continuous Glucose Monitor
Description: a handheld reader and a wearable sensor placed on the back of the arm used to obtain glucose measurements

Intervention type: DEVICE
Intervention: Continuous Glucose Monitor
Description: a handheld reader and a wearable sensor placed on the back of the arm used to obtain glucose measurements

Intervention type: DEVICE
Intervention: Continuous Glucose Monitor
Description: a handheld reader and a wearable sensor placed on the back of the arm used to obtain glucose measurements

Intervention type: DEVICE
Intervention: Wrist Actigraphy Device
Description: a watch like wearable sensor

Intervention type: DEVICE
Intervention: Wrist Actigraphy Device
Description: a watch like wearable sensor

Intervention type: DEVICE
Intervention: Wrist Actigraphy Device
Description: a watch like wearable sensor

Intervention type: DEVICE
Intervention: Food Weight Scale
Description: a scale to measure food weight

Intervention type: DEVICE
Intervention: Food Weight Scale
Description: a scale to measure food weight

Intervention type: DEVICE
Intervention: Food Weight Scale
Description: a scale to measure food weight

Intervention type: DEVICE
Intervention: Smart Body Weight Scale
Description: a full body composition scale that provides fat and muscle mass, water retention, bone mass, and weight trends

Intervention type: DEVICE
Intervention: Smart Body Weight Scale
Description: a full body composition scale that provides fat and muscle mass, water retention, bone mass, and weight trends

Intervention type: DEVICE
Intervention: Smart Body Weight Scale
Description: a full body composition scale that provides fat and muscle mass, water retention, bone mass, and weight trends
Study: NCT04807010

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Prostate Artery Embolization
Description: Prostate artery embolization reduces symptoms from benign prostatic hyperplasia by delivering embolic materials to the prostate through the prostatic arteries.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Prostate Artery Embolization
Description: Prostate artery embolization reduces symptoms from benign prostatic hyperplasia by delivering embolic materials to the prostate through the prostatic arteries.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham Prostate Artery Embolization
Description: Angiogram without embolization initially. At 6 months patients will be allowed to crossover to prostate artery embolization.
Study: NCT05819970

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Allium Sativum Oil
Description: Allium sativum oil will be used as non-vital pulpotomy medicament

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Turmeric Gel
Description: Turmeric gel will be used as non-vital pulpotomy medicament
Study: NCT04904185

Intervention type: DRUG
Group type: OTHER
Intervention: Cyclophosphamide
Description: Cyclophosphamide 500 mg/m2 is administered i.v. on day -4, -3 and -2

Intervention type: DRUG
Group type: OTHER
Intervention: Cyclophosphamide
Description: Cyclophosphamide 500 mg/m2 is administered i.v. on day -4, -3 and -2

Intervention type: DRUG
Group type: OTHER
Intervention: Fludarabine Phosphate
Description: Fludarabine Phosphate 30 mg/m2 is administered on day -4 and -3

Intervention type: DRUG
Group type: OTHER
Intervention: Fludarabine Phosphate
Description: Fludarabine Phosphate 30 mg/m2 is administered on day -4 and -3
Study: NCT05158673

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of Cocoa flavonoids
Description: Dietary supplement: The administration of two capsules of 500 mg orally of placebo (excipient q.s. starch capsule) 1 every 12 hours, for 12 weeks
Study: NCT04904185

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Multiple Antigen Specific Endogenously derived T cells
Description: Antigen specific, ex vivo expanded T cells derived from peripheral blood T cells

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Multiple Antigen Specific Endogenously derived T cells
Description: Antigen specific, ex vivo expanded T cells derived from peripheral blood T cells

Intervention type: DRUG
Group type: OTHER
Intervention: Pembrolizumab
Description: Pembrolizumab 2 mg/kg is administered on day -1 and on day 21. The medicine is administered over 30 minutes
Study: NCT05158673

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Cocoa flavonoids
Description: Dietary supplement: Two 500 mg capsules of the flavonoid supplement (whose total flavonoid content is 15 mg/capsule) orally every 12 hours (one in the morning and one at night) for 12 weeks
Study: NCT06072547

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Access to all varieties of on! 4mg nicotine pouches (Berry, Citrus, Cinnamon, Wintergreen, Mint, Coffee, and Original)
Description: Access to all varieties of on! 4mg nicotine pouch products (Berry, Citrus, Cinnamon, Wintergreen, Mint, Coffee, and Original), throughout the trial.
Study: NCT05486819

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol Injection
Description: adding lignocaine or sodium bicarbonate to propofol to reduce pain during injection

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol Injection
Description: adding lignocaine or sodium bicarbonate to propofol to reduce pain during injection
Study: NCT06021873

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SADI-S
Description: Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SADI-S
Description: Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy
Study: NCT05375942

Intervention type: DRUG
Intervention: Inflectra
Description: 1. To describe the characteristics of patients newly initiated on Inflectra.

Intervention type: DRUG
Intervention: Inflectra
Description: 2. To describe 6-month outcomes after initiating Inflectra, among patients who have 6 months follow-up information in the CorEvitas' RA Registry.
Study: NCT06072547

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Access to Original on! 4mg nicotine pouches
Description: Access to non-flavored (i.e., Original) 4mg on! nicotine pouch products throughout the trial.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non-Flavored then complete flavor on! nicotine pouches
Description: Access to non-flavored (i.e., Original) on! 4mg nicotine pouch products during the first 3 weeks and then access to all varieties (Berry, Citrus, Cinnamon, Wintergreen, Mint, Coffee, and Original) of on! 4mg nicotine pouch products during the rest of the trial
Study: NCT04796259

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Malt ingredient
Description: Solution with malt-derived ingredient

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Malt ingredient
Description: Solution with malt-derived ingredient

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Non-alcoholic beer solids
Description: Solution with non-alcoholic beer solids
Study: NCT04853953

Intervention type: OTHER
Intervention: Incidence of bleeding complications in ARDS patients on veno-venous ECMO
Description: All bleeding complications (especially cerebral bleedings) will be analyzed in the study groups. At the bleeding event, laboratory parameters of coagulation will be collected and the intensity of the ECMO treatment

Intervention type: OTHER
Intervention: Incidence of bleeding complications in ARDS patients on veno-venous ECMO
Description: All bleeding complications (especially cerebral bleedings) will be analyzed in the study groups. At the bleeding event, laboratory parameters of coagulation will be collected and the intensity of the ECMO treatment
Study: NCT05486819

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Propofol Injection
Description: adding lignocaine or sodium bicarbonate to propofol to reduce pain during injection
Study: NCT06666608

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bone Stimulator
Description: Subjects will be asked to wear their device (if applicable) for a minimum of 30 minutes a day for 12 weeks with no maximum usage time. The device will track compliance. Bone stimulator should be worn at rest.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care Spondylolysis Treatment
Description: Participants will follow the standard of care regimen for spondylolysis treatment at Houston Methodist which will involve physical therapy and wearing a back brace.
Study: NCT06723028

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Regulation of craving training
Description: Participants randomized into the active mROC-T intervention (mROC-T+ or mROC-Tc) will: 1. Read a brief essay about either the social justice benefits of eating healthy foods (POSITIVE, mROCT+) or critical of social justice aspects of unhealthy foods (CRITICAL, mROC-Tc). 2. Participants complete six free-response questions to ensure that they understood the essays.~3. Participants are instructed to use the information from the essay. They are shown a cue matching the essay they read either: Think Positive or Think Critically.~4. They are shown an image of a healthy food (no added sugar and \< 2g/serving saturated fat) OR an image of an unhealthy food (contain added sugar and/or \>4.5g/serving saturated fat). 5. Finally, the participant is asked to rate how strong their craving is for the pictured food. The participant indicates their craving on a VAS from 1 (No craving at all) to 5 (Very high craving)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Regulation of craving training
Description: Participants randomized into the active mROC-T intervention (mROC-T+ or mROC-Tc) will: 1. Read a brief essay about either the social justice benefits of eating healthy foods (POSITIVE, mROCT+) or critical of social justice aspects of unhealthy foods (CRITICAL, mROC-Tc). 2. Participants complete six free-response questions to ensure that they understood the essays.~3. Participants are instructed to use the information from the essay. They are shown a cue matching the essay they read either: Think Positive or Think Critically.~4. They are shown an image of a healthy food (no added sugar and \< 2g/serving saturated fat) OR an image of an unhealthy food (contain added sugar and/or \>4.5g/serving saturated fat). 5. Finally, the participant is asked to rate how strong their craving is for the pictured food. The participant indicates their craving on a VAS from 1 (No craving at all) to 5 (Very high craving)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Regulation of craving training
Description: Participants randomized into the active mROC-T intervention (mROC-T+ or mROC-Tc) will: 1. Read a brief essay about either the social justice benefits of eating healthy foods (POSITIVE, mROCT+) or critical of social justice aspects of unhealthy foods (CRITICAL, mROC-Tc). 2. Participants complete six free-response questions to ensure that they understood the essays.~3. Participants are instructed to use the information from the essay. They are shown a cue matching the essay they read either: Think Positive or Think Critically.~4. They are shown an image of a healthy food (no added sugar and \< 2g/serving saturated fat) OR an image of an unhealthy food (contain added sugar and/or \>4.5g/serving saturated fat). 5. Finally, the participant is asked to rate how strong their craving is for the pictured food. The participant indicates their craving on a VAS from 1 (No craving at all) to 5 (Very high craving)